Portfolio Holdings Detail for ISIN IE000X08RX14
| Stock Name / Fund | iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | EDMNZx(NZD) CXE |
Holdings detail for BDX
| Stock Name | Becton Dickinson and Company |
| Ticker | BDX(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US0758871091 |
| LEI | ICE2EP6D98PQUILVRZ91 |
Show aggregate BDX holdings
News associated with BDX
- BDX Factor-Based Stock Analysis - Peter Lynch
- Below is Validea's guru fundamental report for BECTON DICKINSON AND CO (BDX). Of the 22 guru strategies we follow, BDX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price r - 2025-03-12 18:06:14
- Victory Capital Management Inc. Has $24.96 Million Stake in Becton, Dickinson and Company (NYSE:BDX)
- Victory Capital Management Inc. trimmed its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 3.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 110,034 shares of the medical instruments supplier’s stock after selling 4,313 shares […] - 2025-03-11 08:58:57
- Becton, Dickinson and Company (NYSE:BDX) Shares Sold by Sigma Planning Corp
- Sigma Planning Corp lessened its stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 70.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 929 shares of the medical instruments supplier’s stock after selling 2,169 shares during the period. Sigma Planning Corp’s holdings in Becton, Dickinson and Company were worth $211,000 as […] - 2025-03-02 09:55:05
- Becton, Dickinson and Company (NYSE:BDX) Stock Rating Lowered by StockNews.com
- Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday. Several other equities research analysts have also issued reports on BDX. Piper Sandler lifted their target price on shares of Becton, Dickinson and Company […] - 2025-02-27 07:03:01
- Blue Trust Inc. Decreases Stock Holdings in Becton, Dickinson and Company (NYSE:BDX)
- Blue Trust Inc. reduced its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 42.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,542 shares of the medical instruments supplier’s stock after selling 1,157 shares during the quarter. Blue Trust Inc.’s […] - 2025-02-19 13:50:45
- Allspring Global Investments Holdings LLC Grows Holdings in Becton, Dickinson and Company (NYSE:BDX)
- Allspring Global Investments Holdings LLC increased its stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 56.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 45,792 shares of the medical instruments supplier’s stock after acquiring an additional 16,537 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Becton, Dickinson and […] - 2025-02-19 09:54:57
- BD Recalls ChloraPrep Clear 1 ML Applicators
- (RTTNews) - Medical technology company Becton, Dickinson and Co. or BD has recalled one lot of ChloraPrep Clear 1 mL Applicators citing potential fungal contamination, the U.S. Food and Drug Administration said. Under certain environmental conditions, the contamination allows the - 2025-02-19 05:40:43
- Do Wall Street Analysts Like Becton, Dickinson and Company Stock?
- MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential. - 2025-02-17 18:57:12
- Do Wall Street Analysts Like Becton, Dickinson and Company Stock?
- MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential. - 2025-02-17 14:31:49
- U.S. Capital Wealth Advisors LLC Grows Position in Becton, Dickinson and Company (NYSE:BDX)
- U.S. Capital Wealth Advisors LLC grew its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 14.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,224 shares of the medical instruments supplier’s stock after purchasing an […] - 2025-02-07 09:44:43
- Chicago Partners Investment Group LLC Raises Stock Holdings in Becton, Dickinson and Company (NYSE:BDX)
- Chicago Partners Investment Group LLC lifted its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 38.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,250 shares of the medical instruments supplier’s stock after buying an additional 622 shares during […] - 2025-02-04 09:02:59
- Piper Sandler Boosts Becton, Dickinson and Company (NYSE:BDX) Price Target to $280.00
- Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its target price hoisted by analysts at Piper Sandler from $275.00 to $280.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical instruments supplier’s stock. Piper Sandler’s price target indicates a potential upside of 13.43% from […] - 2025-01-30 08:59:09
iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc) BDX holdings
| Date | Number of BDX Shares Held | Base Market Value of BDX Shares | Local Market Value of BDX Shares | Change in BDX Shares Held | Change in BDX Base Value | Current Price per BDX Share Held | Previous Price per BDX Share Held |
|---|
| 2024-11-08 (Friday) | 5,456 | USD 1,263,828 | USD 1,263,828 | 0 | USD 24,716 | USD 231.64 | USD 227.11 |
| 2024-11-07 (Thursday) | 5,456 | USD 1,239,112 | USD 1,239,112 | 0 | USD -70,655 | USD 227.11 | USD 240.06 |
| 2024-11-06 (Wednesday) | 5,456 | USD 1,309,767 | USD 1,309,767 | 0 | USD 15,058 | USD 240.06 | USD 237.3 |
| 2024-11-05 (Tuesday) | 5,456 | USD 1,294,709 | USD 1,294,709 | 0 | USD 16,205 | USD 237.3 | USD 234.33 |
| 2024-11-04 (Monday) | 5,456 | USD 1,278,504 | USD 1,278,504 | 0 | USD -4,965 | USD 234.33 | USD 235.24 |
| 2024-11-01 (Friday) | 5,456 | USD 1,283,469 | USD 1,283,469 | -88 | USD -11,554 | USD 235.24 | USD 233.59 |
| 2024-10-31 (Thursday) | 5,544 | USD 1,295,023 | USD 1,295,023 | 0 | USD -16,743 | USD 233.59 | USD 236.61 |
| 2024-10-30 (Wednesday) | 5,544 | USD 1,311,766 | USD 1,311,766 | 0 | USD -4,989 | USD 236.61 | USD 237.51 |
| 2024-10-29 (Tuesday) | 5,544 | USD 1,316,755 | USD 1,316,755 | 0 | USD -7,762 | USD 237.51 | USD 238.91 |
| 2024-10-28 (Monday) | 5,544 | USD 1,324,517 | USD 1,324,517 | 0 | USD 4,324 | USD 238.91 | USD 238.13 |
| 2024-10-25 (Friday) | 5,544 | USD 1,320,193 | USD 1,320,193 | 0 | USD -2,716 | USD 238.13 | USD 238.62 |
| 2024-10-24 (Thursday) | 5,544 | USD 1,322,909 | USD 1,322,909 | 0 | USD -10,534 | USD 238.62 | USD 240.52 |
| 2024-10-23 (Wednesday) | 5,544 | USD 1,333,443 | USD 1,333,443 | 0 | USD 4,491 | USD 240.52 | USD 239.71 |
| 2024-10-22 (Tuesday) | 5,544 | USD 1,328,952 | USD 1,328,952 | 0 | USD -4,491 | USD 239.71 | USD 240.52 |
| 2024-10-21 (Monday) | 5,544 | USD 1,333,443 | USD 1,333,443 | 0 | USD -17,907 | USD 240.52 | USD 243.75 |
| 2024-10-18 (Friday) | 5,544 | USD 1,351,350 | USD 1,351,350 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of BDX by Blackrock for IE000X08RX14
Show aggregate share trades of BDX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2024-11-01 | SELL | -88 | | | 235.240* | | 238.24 Profit of 20,965 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of BDX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-12 | 435,539 | 104 | 642,487 | 67.8% |
| 2025-03-11 | 390,711 | 0 | 683,087 | 57.2% |
| 2025-03-10 | 348,266 | 291 | 1,105,015 | 31.5% |
| 2025-03-07 | 265,119 | 394 | 720,379 | 36.8% |
| 2025-03-06 | 207,138 | 541 | 909,600 | 22.8% |
| 2025-03-05 | 179,420 | 127 | 870,292 | 20.6% |
| 2025-03-04 | 243,952 | 12 | 550,475 | 44.3% |
| 2025-03-03 | 283,545 | 685 | 544,876 | 52.0% |
| 2025-02-28 | 265,848 | 4,130 | 690,736 | 38.5% |
| 2025-02-27 | 364,880 | 432 | 659,301 | 55.3% |
| 2025-02-26 | 270,787 | 576 | 538,767 | 50.3% |
| 2025-02-25 | 309,613 | 0 | 543,766 | 56.9% |
| 2025-02-24 | 283,036 | 67 | 561,076 | 50.4% |
| 2025-02-21 | 197,642 | 0 | 500,016 | 39.5% |
| 2025-02-20 | 225,846 | 122 | 467,767 | 48.3% |
| 2025-02-19 | 208,659 | 8,967 | 491,028 | 42.5% |
| 2025-02-18 | 217,532 | 26 | 543,678 | 40.0% |
| 2025-02-14 | 208,081 | 0 | 439,709 | 47.3% |
| 2025-02-13 | 311,371 | 3 | 637,854 | 48.8% |
| 2025-02-12 | 303,706 | 55 | 484,439 | 62.7% |
| 2025-02-11 | 307,676 | 45 | 1,066,622 | 28.8% |
| 2025-02-10 | 584,052 | 132 | 997,923 | 58.5% |
| 2025-02-07 | 961,354 | 1 | 1,433,203 | 67.1% |
| 2025-02-06 | 1,280,134 | 413 | 2,652,976 | 48.3% |
| 2025-02-05 | 270,398 | 27 | 674,343 | 40.1% |
| 2025-02-04 | 438,197 | 533 | 1,073,156 | 40.8% |
| 2025-02-03 | 479,943 | 21 | 944,362 | 50.8% |
| 2025-01-31 | 320,883 | 67 | 731,278 | 43.9% |
| 2025-01-30 | 241,672 | 29 | 582,117 | 41.5% |
| 2025-01-29 | 374,914 | 262 | 839,263 | 44.7% |
| 2025-01-28 | 444,010 | 30 | 668,810 | 66.4% |
| 2025-01-27 | 377,646 | 27 | 725,841 | 52.0% |
| 2025-01-24 | 359,115 | 29 | 918,786 | 39.1% |
| 2025-01-23 | 320,908 | 0 | 597,613 | 53.7% |
| 2025-01-22 | 349,189 | 160 | 596,796 | 58.5% |
| 2025-01-21 | 483,316 | 9 | 766,337 | 63.1% |
| 2025-01-17 | 324,855 | 163 | 908,032 | 35.8% |
| 2025-01-16 | 450,264 | 6,561 | 909,659 | 49.5% |
| 2025-01-15 | 613,990 | 2,315 | 1,345,892 | 45.6% |
| 2025-01-14 | 445,413 | 0 | 830,460 | 53.6% |
| 2025-01-13 | 546,357 | 246 | 818,438 | 66.8% |
| 2025-01-10 | 641,020 | 83 | 1,212,430 | 52.9% |
| 2025-01-08 | 294,187 | 11 | 552,376 | 53.3% |
| 2025-01-07 | 341,670 | 60 | 623,841 | 54.8% |
| 2025-01-06 | 418,771 | 179 | 693,257 | 60.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.